Centessa CAO resigns; CFO to add principal accounting officer role; RSU retention grants approved

Centessa Pharmaceuticals plc

Marella Thorell resigns as Chief Accounting Officer effective July 31, 2022, to pursue another opportunity; no disagreement with the company.
CFO Gregory Weinhoff will assume principal accounting officer duties effective July 31, in addition to his CFO role.
Board approved RSU retention grants: CEO Saurabh Saha 750,000 shares, CFO Weinhoff 230,000, EVP Yver 100,000; vest quarterly over 10 quarters starting Sept 30, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Gregory Weinhoff

Chief Financial Officer

CNTA · Centessa Pharmaceuticals plc

Effective: 2022-07-31
Filed: July 8, 2022, 7:59 PM ET

Effective as of July 31, 2022, Gregory Weinhoff, M.D., M.B.A., the Company’s Chief Financial Officer, will assume the duties and responsibilities of the Company’s principal accounting officer, in addition to the Company’s principal financial officer.

Departed

Marella Thorell

Chief Accounting Officer

CNTA · Centessa Pharmaceuticals plc

Effective: 2022-07-31
Successor: Gregory Weinhoff
Filed: July 8, 2022, 7:59 PM ET

On July 1, 2022, Marella Thorell notified Centessa Pharmaceuticals plc (the “Company”) of her decision to resign her position as the Company’s Chief Accounting Officer, and its principal accounting officer, effective as of July 31, 2022 to pursue another professional opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Gregory Weinhoff changed role as Chief Financial Officer at Centessa Pharmaceuticals plc.

Action: assumed duties of principal accounting officer
Role: Chief Financial Officer

Exact text from the filing

Effective as of July 31, 2022, Gregory Weinhoff, M.D., M.B.A., the Company’s Chief Financial Officer, will assume the duties and responsibilities of the Company’s principal accounting officer, in addition to the Company’s principal financial officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Marella Thorell resigned as Chief Accounting Officer at Centessa Pharmaceuticals plc.

Action: resigned
Role: Chief Accounting Officer

Exact text from the filing

On July 1, 2022, Marella Thorell notified Centessa Pharmaceuticals plc (the “Company”) of her decision to resign her position as the Company’s Chief Accounting Officer, and its principal accounting officer, effective as of July 31, 2022 to pursue another professional opportunity.

View on SEC.gov

Centessa Pharmaceuticals plc filing history →

Source: SEC EDGAR

accession 0001847903-22-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.